Presence of kynurenic acid in the mammalian brain - PubMed (original) (raw)
Presence of kynurenic acid in the mammalian brain
F Moroni et al. J Neurochem. 1988 Jul.
Abstract
Kynurenic acid, a tryptophan metabolite able to antagonize the actions of the excitatory amino acids, has been identified and measured for the first time in the brain of mice, rats, guinea pigs, and humans by using an HPLC method. Its content was 5.8 +/- 0.9 in mouse brain, 17.8 +/- 2.0 in rat brain, 16.2 +/- 1.5 in guinea pig brain, 26.8 +/- 2.9 in rabbit brain, and 150 +/- 30 in human cortex (pmol/g wet wt. mean +/- SE). The regional distribution of this molecule was uneven. In rats, guinea pigs, and rabbits, the brainstem was the area richest in this compound. Tryptophan administration (100-300 mg/kg, i.p.) to rats resulted in a significant increase of the brain content of kynurenic acid. Similarly, 1 h after probenecid administration (200 mg/kg, i.p.), the brain content of kynurenate increased by fourfold, thus suggesting that its turnover rate is relatively fast.
Similar articles
- Kynurenic acid is present in the rat brain and its content increases during development and aging processes.
Moroni F, Russi P, Carlá V, Lombardi G. Moroni F, et al. Neurosci Lett. 1988 Nov 22;94(1-2):145-50. doi: 10.1016/0304-3940(88)90285-6. Neurosci Lett. 1988. PMID: 2468114 - Identification and measurement of kynurenic acid in the rat brain and other organs.
Carlá V, Lombardi G, Beni M, Russi P, Moneti G, Moroni F. Carlá V, et al. Anal Biochem. 1988 Feb 15;169(1):89-94. doi: 10.1016/0003-2697(88)90258-8. Anal Biochem. 1988. PMID: 3369691 - Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions.
Russi P, Alesiani M, Lombardi G, Davolio P, Pellicciari R, Moroni F. Russi P, et al. J Neurochem. 1992 Dec;59(6):2076-80. doi: 10.1111/j.1471-4159.1992.tb10097.x. J Neurochem. 1992. PMID: 1431895 - Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats.
Chmiel-Perzyńska I, Perzyński A, Urbańska EM. Chmiel-Perzyńska I, et al. Pharmacol Rep. 2014 Dec;66(6):1134-9. doi: 10.1016/j.pharep.2014.07.014. Epub 2014 Aug 10. Pharmacol Rep. 2014. PMID: 25443746
Cited by
- Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain.
Grilli M, Raiteri L, Patti L, Parodi M, Robino F, Raiteri M, Marchi M. Grilli M, et al. Br J Pharmacol. 2006 Nov;149(6):724-32. doi: 10.1038/sj.bjp.0706914. Epub 2006 Oct 3. Br J Pharmacol. 2006. PMID: 17016503 Free PMC article. - The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. Hilmas C, et al. J Neurosci. 2001 Oct 1;21(19):7463-73. doi: 10.1523/JNEUROSCI.21-19-07463.2001. J Neurosci. 2001. PMID: 11567036 Free PMC article. - High resolution crystal structures of human kynurenine aminotransferase-I bound to PLP cofactor, and in complex with aminooxyacetate.
Nadvi NA, Salam NK, Park J, Akladios FN, Kapoor V, Collyer CA, Gorrell MD, Church WB. Nadvi NA, et al. Protein Sci. 2017 Apr;26(4):727-736. doi: 10.1002/pro.3119. Epub 2017 Mar 6. Protein Sci. 2017. PMID: 28097769 Free PMC article. - Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity.
Staats Pires A, Tan VX, Heng B, Guillemin GJ, Latini A. Staats Pires A, et al. Front Neurosci. 2020 Jun 24;14:620. doi: 10.3389/fnins.2020.00620. eCollection 2020. Front Neurosci. 2020. PMID: 32694973 Free PMC article. Review. - The kynurenine pathway and the brain: Challenges, controversies and promises.
Schwarcz R, Stone TW. Schwarcz R, et al. Neuropharmacology. 2017 Jan;112(Pt B):237-247. doi: 10.1016/j.neuropharm.2016.08.003. Epub 2016 Aug 7. Neuropharmacology. 2017. PMID: 27511838 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources